Catheter timing could cut infections and speed recovery after colorectal surgery

NCT ID NCT06769087

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial tests whether removing the urinary catheter immediately after colorectal cancer surgery (before anesthesia wears off) is as safe and effective as removing it the next day. The goal is to lower the risk of urinary tract infections and help patients recover faster. About 316 adults undergoing colorectal cancer surgery will be randomly assigned to one of the two timing groups, and researchers will track urinary retention, infection rates, and the need for catheter reinsertion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
urinary catheter removal timing (immediate vs. postoperative day 1)
What this could lead to
If removing the catheter immediately after surgery proves safe and effective, it could become a standard practice to reduce urinary tract infections and help patients recover faster after colorectal cancer surgery.
What could go wrong
This is a single-center trial with 316 participants, so results may not apply to all hospitals or patients. Removing the catheter too early may increase the risk of urinary retention requiring reinsertion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seoul St.Mary's hospital, the Catholic university of Korea

    Seoul, Seoul, 06591, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.